Stengone Carmine N., Director at Kiora Pharmaceuticals, holds 1.25K shares in Kiora Pharmaceuticals (Ticker: KPRX), holds ― shares in Contineum Therapeutics, Inc. Class A (Ticker: CTNM). Most recently, Stengone Carmine N. Bought ― shares of Kiora Pharmaceuticals on Sep 12, 2024 for an estimated value of 4.60K.
What is the percentage of profitable transactions made by Stengone Carmine N.?
The percentage of profitable transactions made by Stengone Carmine N. is ―.
What is the average return per transaction made by Stengone Carmine N.?
The average return per transaction made by Stengone Carmine N. is ―.
What stocks does Stengone Carmine N. hold?
Stengone Carmine N. holds: KPRX, CTNM stocks.
What was Stengone Carmine N.’s latest transaction?
Stengone Carmine N. latest transaction was an Informative Buy of $4.60K.
What was Stengone Carmine N.'s most profitable transaction?
Stengone Carmine N.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stengone Carmine N.'s role in Kiora Pharmaceuticals?
Stengone Carmine N.'s role in Kiora Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.